Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VolitionRX Limited Common Stock (NY:VNRX)

0.4444 -0.0437 (-8.95%)
Official Closing Price Updated: 8:00 PM EDT, Aug 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 531,771
Open 0.4924
Bid (Size) 0.4400 (300)
Ask (Size) 0.4465 (400)
Prev. Close 0.4881
Today's Range 0.4349 - 0.5214
52wk Range 0.4349 - 14.80
Shares Outstanding 122,801,572
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Volition (VNRX) Q2 2026 Earnings Call Transcript ↗
Revenue flat as cost cuts narrowed losses and cash strengthened. 
Via The Motley Fool
Topics Death Earnings
News headline image
VolitionRX Reports Q2 2026 Results: Full Earnings Call Transcript ↗
On Friday, VolitionRX (AMEX:VNRX) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call... 
Via Benzinga
Topics Earnings

Performance

YTD
-91.9%
-91.9%
1 Month
-60.0%
-60.0%
3 Month
-83.5%
-83.5%
6 Month
-89.2%
-89.2%
1 Year
-96.6%
-96.6%

More News

Read More
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Reports Strong Correlation for Finger-Prick Nu.Q NETs Prototype in Sepsis Patients
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Publishes Peer-Reviewed Capture-Seq Study
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Highlights Growing Clinical Evidence Supporting Nu.Q NETs Test
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Study Highlights Prognostic Value of Nu.Q Cancer Assay in Lung Cancer
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Collaborates with Sysmex to Advance Nu.Q® NETs Assay Development
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Expands Patent Portfolio with Ebola Triage Application
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Highlights Clinical and Commercial Progress Across Diagnostics Portfolio
Via Investor Brand Network
News headline image
BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Reports High Accuracy In Feline Cancer Blood Test Study
Via Investor Brand Network
InvestorNewsBreaks – VolitionRx Ltd. (NYSE American: VNRX) Reports Finger-Prick Breakthrough for Nucleosome Detection in Sepsis
Via Investor Brand Network
Which stocks are most active on Wednesday? ↗
Via Chartmill
These stocks have an unusual volume in today's session ↗
Via Chartmill
InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Over 95% Early-Stage Cancer Detection Using Capture-Seq Technology
Via Investor Brand Network
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
These stocks are the most active in today's session ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill
InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Breakthrough in Liquid Biopsy With Over 99% Cancer DNA Purity
Via Investor Brand Network
News headline image
Why VNRX Stock Is Soaring Over 70% In Pre-Market Today? ↗
Via Stocktwits
InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Completes Automation Validation for Nu.Q Vet Cancer Test in Japan
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Reports Multi-Pillar Clinical and Commercial Progress
Via Investor Brand Network
InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Appoints MBL as Distributor for Nu.Q(R) Discover Assays in Japan
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
Via Investor Brand Network
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill

Frequently Asked Questions

Is VolitionRX Limited Common Stock publicly traded?
Yes, VolitionRX Limited Common Stock is publicly traded.
What exchange does VolitionRX Limited Common Stock trade on?
VolitionRX Limited Common Stock trades on the New York Stock Exchange
What is the ticker symbol for VolitionRX Limited Common Stock?
The ticker symbol for VolitionRX Limited Common Stock is VNRX on the New York Stock Exchange
What is the current price of VolitionRX Limited Common Stock?
The current price of VolitionRX Limited Common Stock is 0.4444
When was VolitionRX Limited Common Stock last traded?
The last trade of VolitionRX Limited Common Stock was at 08/20/26 08:00 PM ET
What is the market capitalization of VolitionRX Limited Common Stock?
The market capitalization of VolitionRX Limited Common Stock is 54.57M
How many shares of VolitionRX Limited Common Stock are outstanding?
VolitionRX Limited Common Stock has 55M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.